no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Azilsartan Medoxomil: A New Angiotensin Receptor Blocker
|
Zaiken, Kathy |
|
2011 |
33 |
11 |
p. 1577-1589 13 p. |
article |
2 |
Budget Impact Analysis of Conversion from Intravenous to Oral Medication When Clinically Eligible for Oral Intake
|
Lau, Brandyn D. |
|
2011 |
33 |
11 |
p. 1792-1796 5 p. |
article |
3 |
Call for a Moratorium on Routine Liver Function Testing in Patients Treated With HMG-CoA Reductase Inhibitors (Statins)
|
Lehmann, David F. |
|
2011 |
33 |
11 |
p. 1696-1697 2 p. |
article |
4 |
Changes in Herb and Dietary Supplement Use in the US Adult Population: A Comparison of the 2002 and 2007 National Health Interview Surveys
|
Wu, Chung-Hsuen |
|
2011 |
33 |
11 |
p. 1749-1758 10 p. |
article |
5 |
Correction
|
|
|
2011 |
33 |
11 |
p. 1851- 1 p. |
article |
6 |
Denosumab for the Reduction of Bone Loss in Postmenopausal Osteoporosis: A Review
|
Bridgeman, Mary Barna |
|
2011 |
33 |
11 |
p. 1547-1559 13 p. |
article |
7 |
Dosing Patterns for Duloxetine and Predictors of High-Dose Prescriptions in Patients With Major Depressive Disorder: Analysis from a United States Third-Party Payer Perspective
|
Liu, Xianchen |
|
2011 |
33 |
11 |
p. 1726-1738 13 p. |
article |
8 |
Economic Evaluation of Clodronate and Zoledronate in Patients Diagnosed With Metastatic Bone Disease From the Perspective of Public and Third Party Payors in Brazil
|
Cunio Machado Fonseca, Marcelo |
|
2011 |
33 |
11 |
p. 1769-1780.e2 176232 p. |
article |
9 |
Editorial Board
|
|
|
2011 |
33 |
11 |
p. IFC- 1 p. |
article |
10 |
Editorial Board
|
|
|
2011 |
33 |
11 |
p. IBC- 1 p. |
article |
11 |
Efficacy and Safety of Prandial Premixed Therapy Using Insulin Lispro Mix 50/50 3 Times Daily Compared With Progressive Titration of Insulin Lispro Mix 75/25 or Biphasic Insulin Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes Mellitus: A Randomized, 16-Week, Open-Label Study
|
Farcasiu, Eugenia |
|
2011 |
33 |
11 |
p. 1682-1693 12 p. |
article |
12 |
Eltrombopag: An Oral Thrombopoietin Receptor Agonist for the Treatment of Idiopathic Thrombocytopenic Purpura
|
Zhang, Yang |
|
2011 |
33 |
11 |
p. 1560-1576 17 p. |
article |
13 |
Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents
|
Valentine, William J. |
|
2011 |
33 |
11 |
p. 1698-1712 15 p. |
article |
14 |
Extended-Release Quetiapine as Monotherapy for the Treatment of Adults With Acute Mania: A Randomized, Double-Blind, 3-Week Trial
|
Cutler, Andrew J. |
|
2011 |
33 |
11 |
p. 1643-1658 16 p. |
article |
15 |
Focus on Phosphodiesterase Inhibitors for the Treatment of Erectile Dysfunction in Older Men
|
Lee, Mary |
|
2011 |
33 |
11 |
p. 1590-1608 19 p. |
article |
16 |
Hip and Subtrochanteric or Diaphyseal Femoral Fractures in Alendronate Users: A 10-Year, Nationwide Retrospective Cohort Study in Taiwanese Women
|
Hsiao, Fei-Yuan |
|
2011 |
33 |
11 |
p. 1659-1667 9 p. |
article |
17 |
Influence of Hepatic Impairment on the Pharmacokinetics and Safety Profile of Dapagliflozin: An Open-Label, Parallel-Group, Single-Dose Study
|
Kasichayanula, Sreeneeranj |
|
2011 |
33 |
11 |
p. 1798-1808 11 p. |
article |
18 |
Institutional Perspective on the Impact of Positive Blood Cultures on the Economic and Clinical Outcomes of Patients With Complicated Skin and Skin Structure Infections: Focus on Gram-Positive Infections
|
Micek, Scott T. |
|
2011 |
33 |
11 |
p. 1759-1768.e1 15922 p. |
article |
19 |
Intensifying Insulin Therapy in Type 2 Diabetes Mellitus: Dosing Options for Insulin Analogue Premixes
|
Tibaldi, Joseph M. |
|
2011 |
33 |
11 |
p. 1630-1642 13 p. |
article |
20 |
One-Year Treatment Persistence and Potential Adverse Events Among Patients With Atrial Fibrillation Treated With Amiodarone or Sotalol: A Retrospective Claims Database Analysis
|
Kim, Michael H. |
|
2011 |
33 |
11 |
p. 1668-1681.e1 15143 p. |
article |
21 |
Pharmacokinetic Comparison of a New Sustained-Release Formulation of Glimepiride/Metformin 1/500 mg Combination Tablet and a Sustained-Release Formulation of Glimepiride/Metformin 2/500 mg Combination Tablet in Healthy Korean Male Volunteers: A Randomized, 2-Sequence, 2-Period, 2-Treatment Crossover Study
|
Shin, Kwang-Hee |
|
2011 |
33 |
11 |
p. 1809-1818 10 p. |
article |
22 |
Pharmacokinetics, Pharmacodynamics, and Comparative Bioavailability of Single, Oral 2-mg Doses of Dexamethasone Liquid and Tablet Formulations: A Randomized, Controlled, Crossover Study in Healthy Adult Volunteers
|
Queckenberg, Christian |
|
2011 |
33 |
11 |
p. 1831-1841 11 p. |
article |
23 |
Population Pharmacokinetic and Pharmacodynamic Modeling of High-Dose Intermittent Ticarcillin-Clavulanate Administration in Pediatric Cystic Fibrosis Patients
|
Zobell, Jeffery T. |
|
2011 |
33 |
11 |
p. 1844-1850 7 p. |
article |
24 |
Relationship Between Patient-Reported Chronic Low Back Pain Severity and Medication Resources
|
Taylor-Stokes, Gavin |
|
2011 |
33 |
11 |
p. 1739-1748 10 p. |
article |
25 |
Risk Factors for Hypoglycemia-Related Hospitalization in Patients With Type 2 Diabetes: A Nested Case–Control Study
|
Quilliam, Brian J. |
|
2011 |
33 |
11 |
p. 1781-1791 11 p. |
article |
26 |
Table of Contents
|
|
|
2011 |
33 |
11 |
p. OFC- 1 p. |
article |
27 |
The Economic Impact and Cost-Effectiveness of Urinary Neutrophil Gelatinase-Associated Lipocalin After Cardiac Surgery
|
Shaw, Andrew D. |
|
2011 |
33 |
11 |
p. 1713-1725 13 p. |
article |
28 |
Tolerability and Pharmacokinetics of Lobeglitazone (CKD-501), a Peroxisome Proliferator-Activated Receptor-γ Agonist: A Single- and Multiple-Dose, Double-Blind, Randomized Control Study in Healthy Male Korean Subjects
|
Kim, Jung Won |
|
2011 |
33 |
11 |
p. 1819-1830 12 p. |
article |
29 |
Tolerability of Dipeptidyl Peptidase-4 Inhibitors: A Review
|
Richard, Kathleen R. |
|
2011 |
33 |
11 |
p. 1609-1629 21 p. |
article |